Dialectic Behaviour Therapy (DBT) for People With Autism: A Multiple Baseline Single Case Design (DGT-ASS)
2026年8月25日 更新者：GGZ Friesland
Dialectic Behaviour Therapy (DBT) for People With Autism, Emotion Regulation Difficulties and Self-harm Behaviour: A Multiple Baseline Single Case Design
The goal of this experimental study is to test the effectiveness of Dialectic Behavioural Therapy in patients with Autism Spectrum Disorder. The aim questions are:
- What is the effect of DBT on maladaptive emotion regulation strategies and emotional well-being in patients with ASD?
- Is the use of DBT skills associated with a reduction in maladaptive emotion regulation strategies and an increase of emotional well-being over time?
- What are the dynamics over time between maladaptive emotion regulation strategies, emotional well-being and sensory overload?
Participants will:
- Follow DBT of 10 months
- Keep a diary on their urge of maladaptive emotion regulation strategies and well-being
研究概览
研究类型
介入性
注册 (估计的)
6
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习联系方式
- 姓名：Emma Smeenge
- 电话号码：+31610779265
- 邮箱：emma.smeenge@ggzfriesland.nl
学习地点
-
-
Provincie Friesland
-
Leeuwarden、Provincie Friesland、荷兰、8934AD
- 招聘中
- GGZ Friesland
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- DSM-5 diagnosis of ASD
- Sufficient understanding, as demonstrated in conversation with intake therapist;
- Explicit behavioural problems, which, according to patient and therapist, lead to functional problems (like suicidal ideation, auto mutilation, emotional outburst and interpersonal conflicts);
- BMI > 17;
- Commitment to the therapy and shared goals as assessed by intake therapist;
Exclusion Criteria:
- Antisocial behaviour which interrupts the group climate;
- Presence of a trauma-related disorder that is likely to interfere with the ability to engage effectively in DBT or that requires specialized trauma-focused treatment prior to or alongside DBT as assessed by intake team;
- Excessive dependency on substances for which no parallel appropriate policy can be made;
- Diagnosis of psychotic disorder if not stable;
- Diagnosed with bipolar disorder.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Dialectic Behavioural Therapy
Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder, given for 10 months
|
Dialectic Behavioural Therapy for emotion regulation, adapted to individuals with Autism Spectrum Disorder
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Maladaptive Emotion Regulation Strategies (MERS) measured assessed by the DBT diary (Linehan, 2016)
大体时间：From enrollment to end of treatment at 10 months
|
MERS is the average of the urge to six maladaptive emotion regulation strategies:
|
From enrollment to end of treatment at 10 months
|
|
Emotional well-being as assessed by the DBT diary (Linehan, 2016)
大体时间：From enrollment to end of treatment at 10 months
|
The daily diary measures emotional suffering and happiness on a scale from 0 - 100.
Emotional suffering is inverted, following the logic that higher emotional suffering means lower emotional well-being.
The variable well-being is created by averaging the invert of emotional suffering and happiness.
|
From enrollment to end of treatment at 10 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Social behaviour
大体时间：At start of baseline (T1), at end of treatment phase at 10 months (T2)
|
As measured by the Vragenlijst Inventarisatie van Sociaal gedrag bij Volwassenen (VIS-V) (Horwitz et al. 2013).
The VIS-V is a 44-item questionnaire that assess social behaviour, with answers ranging from 0 (= not applicable) to 2 (=cleary applicable).
Higher scores mean lower social behaviour.
|
At start of baseline (T1), at end of treatment phase at 10 months (T2)
|
|
Emotion regulation
大体时间：At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
|
As measured with the Difficulties in Emotion Regulation Scale (DERS) (Gratz & Roemer, 2004).
The DERS is a 36-item questionnaire with 5-point Likert answers, ranging from "almost never" to "almost always".
|
At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
|
|
Generic psychopathology and functioning
大体时间：At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
|
As measured with the Outcome Questionnaire-45 (OQ-45) (De Jong et al., 2008).
The OQ-45 is a 45-item questionnaire, with answers ranging from never (0) to almost always (4).
Some items are mirrored.
|
At the start of the baseline phase (T1), at the end of the treatment phase at 10 months (T2)
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年9月1日
初级完成 (估计的)
2027年8月1日
研究完成 (估计的)
2028年2月1日
研究注册日期
首次提交
2026年8月12日
首先提交符合 QC 标准的
2026年8月25日
首次发布 (实际的)
2026年8月26日
研究记录更新
最后更新发布 (实际的)
2026年8月26日
上次提交的符合 QC 标准的更新
2026年8月25日
最后验证
2026年7月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2025/666
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
不
IPD 计划说明
To protect the participants of the study
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.